I am Ken Karapetyan, PhD in Chemistry, and I am holding multiple professional certifications (e.g. PMP, Scrum, and Disruptive Innovation, etc).
In last 20 years I have been a product and a business leader in large pharma companies like Bayer and Merck KGaA, in publishing and data analytics companies like Elsevier of RELX group and Royal Society of Chemistry, and research institutes like National Center of Biotechnology Information of National Institutes of Health in the US. I have progressed from cheminformatics application developer, to IT project management, and finally to software product management. I have led teams of product managers, as well as cross-functional teams of product managers, software developers, UX specialists, sales, and marketing.
Background & Expertise:
Life Sciences Leadership: Trained as a computational chemist, I am well-versed in the challenges and workflows of biopharma industry
Digital Product Leadership: Gained deep product insights through 100+ user workshops, interviews, surveys, and ‘Voice of the Customer’ studies.Demonstrated expertise in formulating product vision, strategy, and roadmaps.Proven ability in leading products from ideation to market launch, leveraging methodologies such as Lean Startup, Lean Canvas, Design Thinking, and Jobs-to-be-Done.Advanced proficiency in UI/UX design principles and user research techniques, including the use of UI heat maps and A/B tests
Enterprise Software Development: With prior experience in software development and technical leadership, I specialize in spearheading the development of complex, AI/data-driven enterprise software solutions. My foundation in Scrum, Kanban, and project management has consistently enhanced project efficiency and team productivity.
Marketing & Sales Strategist: Skilled in crafting and executing marketing and sales strategies, including comprehensive Go-To-Market plans
Cross-Functional Team Leadership:Proven leadership of global cross-functional teams of 40+ people, fostering collaboration, innovation, and achieving results in matrixed organizational structures
